Loading data
PRLDNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 12.14 m USD | 7 m USD | — | — | — |
| Research and development expense | 94.3 m USD | 118 m USD | 103.39 m USD | 92.89 m USD | 86.78 m USD |
| Operating profit | -104.57 m USD | -139.71 m USD | -132.28 m USD | -123.54 m USD | -113.74 m USD |
| Income tax expense | 0 USD | 0 USD | — | — | — |
| Net income (reported basis) | -99.5 m USD | -127.17 m USD | -121.83 m USD | -115.44 m USD | -111.69 m USD |
| Basic earnings per share | -1.29 USD/share | -1.68 USD/share | -2.02 USD/share | -2.44 USD/share | -2.43 USD/share |
| Diluted earnings per share | -1.29 USD/share | -1.68 USD/share | -2.02 USD/share | -2.44 USD/share | -2.43 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.